1. HOME
  2. »
  3. LATEST NEWS / EVENTS
  4. »
  5. Page 4
  • All
  • LATEST NEWS
  • UPCOMING EVENTS

CarthaGenetics® Iberica will participate in the benefit gala “Desitjos Enlaire” organized by MPS España for the “15th Anniversary of the MPS Association” on July 13th at 21:00 in Igualada Barcelona. http://www.mpsesp.org.tr/ Do not hesitate to contact us: Philippe Carteron our CEO at (phcarteron@carthagenetics.com) and Samira Benmansour our...

Nobel Ilac is a full-cycle Turkish pharmaceutical company founded in 1964, producing world-class pharmaceuticals for human health. Nobel Ilac provides a global presence of outstanding, reliable and accessible products for human health. CarthaGenetics® is focusing on finding innovative early patients access to medicines for supplying the...

After having served the Turkish rare diseases community for many years from Ankara, we are happy to annouce that CarthaGenetics® is now also established in Istanbul with its new office in. Nidakule KozyatagiKozyatagi MahallesiDegirmen Sk. 18/19B, Kat 1034742 Kadikoy/IstanbulTurkey We look forward to receiving you there. ...

CarthaGenetics® will attend BioPharm America from 5th to 6th of September 2018 in Hynes Convention Center, Boston, MA.If you would like to arrange a meeting with us, do not hesitate to contact our CEO Philippe Carteron de Balmont at(phcarteron@carthagenetics.com) . ...

Nativa LLC is a full-cycle Russian pharmaceutical company founded in 2010, developing and producing world-class complex medicaments essential for human health. It focuses on oncology, pulmonology, multiple sclerosis and other fields. CarthaGenetics® is focusing on finding innovative early patients access to medicines for treating unmet needs and...

Turkish health sector has been changed completely with the Health Transformation Project lead by Ministry of Health. In this process of change, healthcare providers have become more competitive in healthcare market. As a result of project the health expenditures has beenincreased and policy makers implemented...

The book titled as “Pharmaceutical Market Access in Developed Markets” under Dr. Guvenc Kockaya (CarthaGenetics market Access Director) and Prof. Albert Wert heimer’s editorialship has been published for pre-order on Amazon. Market access is the process by which a pharmaceutical company gets its product available on...

Copy link
Powered by Social Snap